Amy Sullivan
CIK 1887865 · Chief Financial Officer · last filed 2025-04-04
Amy Sullivan is a Chief Financial Officer who has filed 7 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for IOBT, was dated Apr 4, 2025. Across all open-market trades the lifetime net is +$66.5K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
7
$66.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IO Biotech, Inc. (IOBT) Delisted | Chief Financial Officer | 84,632 | $0.05 | $4.1K | $66.5K | 7 | 2025-04-04 |
Recent Filings
7 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-04 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-23 | IO Biotech, Inc. (IOBT) Delisted | Buy (P) | +10,250 | $8.5K | EDGAR |
| 2024-03-18 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-08-09 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | +49,382 | $93.8K | EDGAR |
| 2023-03-22 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-20 | IO Biotech, Inc. (IOBT) Delisted | Buy (P) | +25,000 | $58.0K | EDGAR |
| 2022-10-19 | IO Biotech, Inc. (IOBT) Delisted | Grant (A) | — | $0 | EDGAR |